Sterling’s facility in Cary, North Carolina provides us with a physical presence close to the pharmaceutical and biotech hub, Research Triangle Park.

We deliver expert chemistry solutions for pre-clinical and early phase clinical supply from the facility and can cater for volumes from millilitres up to 100-litre batches, ideal for small volume products or products in the early stages of clinical trials.

Our facility features cGMP API manufacturing capabilities and allows us to produce high value, low volume APIs including high barrier to entry compounds that are generally difficult to manufacture.

In this video our President US Operations, Mat Minardi, gives an overview of the US facility and the team’s expertise.

For more information, or to speak to a member of the Sterling team, please get in touch.